HCPLive Network

Kidney Disease Greatly Reduces Life Expectancy in Systemic Lupus Erythematosus

MONDAY, July 8 (HealthDay News) -- For patients with systemic lupus erythematosus (SLE), compromised kidneys significantly reduce survival and life expectancy, according to a study published online June 10 in Arthritis & Rheumatism.

To examine the effect of renal disease on standardized mortality ratios (SMRs) and life expectancy of patients with SLE, Chi Chiu Mok, MD, from Tuen Mun Hospital in Hong Kong, and colleagues analyzed longitudinal data (1995 to 2011) from 694 patients with four or more American College of Rheumatology criteria for SLE (92 percent women; age of onset, 32.9 ± 13.4 years).

The researchers found that 53 percent of patients had renal disease. After a mean of 9.6 years, renal damage was present in 11 percent of patients, and 3 percent developed end-stage renal disease (ESRD). Compared to patients without, those patients with renal disease, renal damage, and ESRD had significantly increased age- and sex-adjusted hazard ratios for mortality (2.23, 3.59, and 9.20, respectively). There was a significant increase in mortality associated with proliferative types, but not pure membraneous, lupus nephritis (adjusted hazard ratio, 2.28 [P = 0.01] and 1.09 [P = 0.88], respectively). Non-renal SLE patients, patients with lupus nephritis, proliferative nephritis, pure membranous nephritis, renal damage, and ESRD had age- and sex-adjusted SMRs of 4.8, 9.0, 9.8, 6.1, 14.0, and 63.1, respectively. For SLE patients with renal disease and renal damage, life expectancy was reduced by 15.1 and 23.7 years, respectively, compared with the population.

"The presence of renal disease, in particular proliferative nephritis causing renal insufficiency, significantly reduces survival and life expectancy of SLE patients," the authors write.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2013 HealthDay. All rights reserved.

Further Reading
Interim study results presented at ACG 2014 indicate that treatment with vedolizumab safely and effectively maintains long-term clinical remission and response in patients with Crohn’s disease and ulcerative colitis.
A child receives the wrong medication or the wrong dosage every 8 minutes in the United States, according to a study published online Oct. 20 in Pediatrics.
A three-minute diagnostic assessment (3D-Confusion Assessment Method) has high sensitivity and specificity for identifying delirium, according to a study published in the Oct. 21 issue of the Annals of Internal Medicine.
In the era of rapidly improving cure rates for hepatitis C infection, has the importance of staging as part of treatment diminished?
The fate of Bentley, the pet dog of hospitalized Dallas Ebola victim Nina Pham has been of great interest to animal lovers. But scientists are also paying attention. No one expects the dog to get sick, but many are curious whether he will show signs of being infected. Dogs can apparently carry the Ebola virus without getting the illness. The question is whether they can transmit it to people.
Study results show that patients suffering from active inflammatory bowel disease (IBD) are at risk for poor prognoses following an initial myocardial infarction.
New research provides some of the first concrete support for a treatment guideline that has long been recommended on grounds of common sense alone: Patients who suffer severe allergic reactions such as anaphylaxis should follow up on their emergency room care by seeing an allergist or immunologist.
More Reading